Chang Tm
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
-
- Hemoglobin structure and function
Papers in
-
- Metabolism and Genetic Disorders 6
- Surgery 6
- Pancreatic function and diabetes 3
- Co-authors
- C. Lister (2 shared papers)A. Gonda (1 shared paper)C W Cole (1 shared paper)Sujith Kuruvilla (1 shared paper)G Moss (1 shared paper)Martha Farmer (1 shared paper)S. Sideman (1 shared paper)Paul E. Barré (1 shared paper)
- Journals
- The International Journal of Artificial Organs (1 paper)PubMed (34 papers)
- Partner nations
- Canada
In The Last Decade
Chang Tm
34 papers receiving 431 citations
Peers
Comparison fields: 5 of 74
- Hepatology 73
- Cell Biology 82
- Nephrology 30
- Surgery 168
- Critical Care and Intensive Care Medicine 18
Countries citing papers authored by Chang Tm
This map shows the geographic impact of Chang Tm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Tm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Tm more than expected).
Fields of papers citing papers by Chang Tm
This network shows the impact of papers produced by Chang Tm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Tm. The network helps show where Chang Tm may publish in the future.
Co-authors
The 11 scholars most cited alongside Chang Tm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. | 1976 | 76 |
| 2 | Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. | 1990 | 51 |
| 3 | Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. | 1975 | 35 |
| 4 | Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. | 1978 | 29 |
| 5 | Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal. | 1971 | 27 |
| 6 | Assessments of clinical trials of charcoal hemoperfusion in uremic patients. | 1979 | 24 |
| 7 | In vivo assessment of pyridoxylated crosslinked polyhemoglobin as an artificial red cell substitute in rats. | 1983 | 24 |
| 8 | Clincial performance characteristics of a new combined system for simulatenous hemoperfusion-hemodialysis-ultrafiltration in series. | 1975 | 21 |
| 9 | Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure. | 1976 | 20 |
| 10 | Microcapsule artificial kidney: including updated preparative procedures and properties. | 1976 | 19 |
| 11 | Comparisons of six artificial liver support regimes in fulminant hepatic coma rats. | 1980 | 18 |
| 12 | Blood compatible coating of synthetic immunoadsorbents. | 1980 | 16 |
| 13 | Preliminary report on effects of prostaglandin E2 on brain edema in fulminant hepatic failure rats. | 1985 | 10 |
| 14 | Artificial red blood cells. | 1980 | 10 |
| 15 | Phase one clinical trial of a new composite artificial kidney: a single unit combining dialysis with hemoperfusion. | 1982 | 9 |
| 16 | Biomedical applications of artificial cells. | 1973 | 7 |
| 17 | Lipid-nylon membrane artificial cells containing multienzyme systems, cofactors and substrates for the sequential conversion of ammonia and urea into glutamate. | 1981 | 7 |
| 18 | The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats. | 1982 | 6 |
| 19 | Conversion of ammonia or urea into L-leucine, L-valine, and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD+. Glucose dehydrogenase for co-factor recycling. | 1988 | 6 |
| 20 | In-vitro assessment of the removal of phenols by ACAC hemoperfusion. | 1979 | 6 |
About Chang Tm
Chang Tm is a scholar working on Clinical Biochemistry, Surgery, Molecular Biology, Physiology and Public Health, Environmental and Occupational Health, having authored 35 papers that have together received 471 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (6 papers), Enzyme Catalysis and Immobilization (4 papers), Blood donation and transfusion practices (3 papers), Pancreatic function and diabetes (3 papers), Organ Donation and Transplantation (3 papers), Amino Acid Enzymes and Metabolism (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (73 citations), Cell Biology (82 citations), Nephrology (30 citations), Surgery (168 citations) and Critical Care and Intensive Care Medicine (18 citations). Chang Tm has collaborated with scholars based in Canada. Frequent co-authors include C. Lister, A. Gonda, C W Cole, Sujith Kuruvilla, G Moss, Martha Farmer, S. Sideman, Paul E. Barré, Róbert Langer and Perry J. Blackshear. Their work appears in journals such as The International Journal of Artificial Organs and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.